The official blog of the Lung Institute.

World COPD Day 2016

16 Nov 2016
| Under COPD, Lung Disease, Medical | Posted by | 0 Comments
World COPD Day 2016

November is National COPD Awareness Month. This year, World COPD Day 2016 will be held on Wednesday, November 16, 2016. The purpose of World COPD Day 2016 is to help raise awareness about chronic obstructive pulmonary disease (COPD).

What is World COPD Day 2016?

Organized by the Global Initiative for Chronic Obstructive Lung Diseases (GOLD) and in collaboration with COPD patient groups and health care professionals across the world, World COPD Day is an event with the goal to raise awareness about COPD and to help improve care internationally.

Traditionally, World COPD Day is held on the third Wednesday in November, and the first World COPD Day was held in 2002. Since the first event, 50 countries worldwide have joined together, making World COPD Day one of the most important COPD awareness and education events.

The theme for World COPD Day 2016 is “Breathe in the Knowledge,” inviting people to better understand COPD, help raise awareness about the pulmonary condition to others and improve COPD care worldwide.

What is COPD?

COPD is a progressive form of chronic lung disease and is characterized by the restriction of airflow into and out of the lungs. In fact, COPD encompasses emphysema and chronic bronchitis. COPD affects everyone differently and at varying rates of progression. Many people with COPD experience symptoms such as shortness of breath, constant coughing, wheezing and fatigue.

Men and women can develop COPD. Typically, COPD develops later in life, causing problems for people who are over 40 years old. However, there are some cases of COPD in younger people as well.

The number one cause of COPD is smoking. Former and current cigarette smokers are at the highest risk of developing COPD. Long-term exposure to air pollutants, dust, chemical fumes and other occupational and environmental hazards can also cause COPD. For some people, COPD develops because of a rare genetic disorder, called alpha-1 antitrypsin deficiency.

While there is no cure for COPD, treatment options such as medications, oxygen therapy, pulmonary rehab and stem cell therapy are available. Traditional medications and treatments work to manage COPD symptoms. However, stem cell therapy works to promote healing from within the lungs, potentially addressing the disease itself and improving lung function.

How can I get involved in World COPD Day 2016?

World COPD Day 2016

There are many ways for you to get involved in World COPD Day 2016. You can start by helping to raise awareness about COPD and educating your friends, family, coworkers and community.

If you’re hosting a World COPD Day 2016 event, you can send information about your activity to the GOLD website, and it could be posted on their site. Also, you can spread the word about your event in your local community to excite people to come learn more.

Join us for World COPD Day 2016 and be part of the movement to raise COPD awareness.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.